CZ830 is an mTOR inhibitor. CB830 showed moderate submicromolar affinity for mTOR and exhibited high selectivity of more than 100-fold over other lipid kinases from the same family, namely, phosphatidylinositide 3-kinases (PI3K) α/β/γ/δ and DNAdependent protein kinase (DNAPK).
1333108-58-9 结构式
